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Abstract 
There is a growing field of research into the physicochemical properties of metal oxide 
nanoparticles (NPs) and their potential use against tumor formation, development and 
progression. Coated NPs with biocompatible surfactants can be incorporated into the 
natural metabolic pathway of the body and specifically favor delivery to the targeted 
cancerous cells versus normal cells. Polyethylene glycol (PEG) is an FDA approved, 
biocompatible synthetic polymer and PEGylated NPs are regarded as "stealth" 
nanoparticles, which are not recognized by the immune system. Herein, PEGylated 
cupric oxide nanoparticles (CuO NPs) with either PEG 1000 or PEG 8000 were 
hydrothermally prepared upon properly adjusting the reaction conditions. Depending 
on the reaction time CuO NPs in the range of core sizes 11-20 nm were formed, while 
hydrodynamic sizes substantially varied (330-1120 nm) with improved colloidal 
stability in PBS. The anticancer activity of the NPs was evaluated on human cervical 
carcinoma HeLa cells by using human immortalized embryonic kidney 293 FT cells as 
a control. Viability assays (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, MTT) revealed that CuO NPs could selectively reduce viability of tumor cells 
(IC50 values 11.91 – 25.78 μg/mL). Reactive oxygen species (ROS) production, cell 
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membrane damage and apoptotic DNA laddering were also evident by nitroblue 
tetrazolium (NBT) reduction, lactate dehydrogenase (LDH) release assays and DNA 
electrophoresis, respectively. CuO NPs strongly inhibited lipoxygenase (LOX) 
enzymatic activity with IC50 values 4 - 5.9 μg/mL, highlighting in that manner their anti-
inflammatory activity. 
   
Keywords: Copper oxide nanoparticles, Anticancer activity, Anti-inflammatory 
activity 
Introduction 
Nanotechnology plays an important role in therapies of the future as “nanomedicine”, 
by allowing to decrease the required efficient dose as well as to increase the therapeutic 
indices and safety profiles of new therapeutics.1 In so, new types of anticancer agents 
are being explored that have the potential to overcome problems with the existing 
anticancer therapies while focusing on better selectivity, efficacy in lower doses and 
decrease of their side effects.2 Their anticancer activity is believed to be mediated either 
directly by their antioxidant action or indirectly through heating. Among them, metal 
oxide nanoparticles (NPs) are under intense investigation mainly from a toxicity point 
of view, due to the detrimental effects reported on cells.3,4 Those NPs have the ability 
to perturb the cell membranes, to degrade the DNA and to react with proteins either 
directly or indirectly by producing reactive oxygen species (ROS). Meanwhile, another 
aspect is to utilize these adverse effects in order to induce death of tumor cells.5 For 
example, by comparing “naked” commercial transition metal oxide NPs, the chemical 
composition was found to be the crucial factor affecting their ability to kill cells with 
the rank of cytotoxicity being CeO2 < Al2O3 <SiO2 < ZnO < CuO.
6 Their activity was 
mediated by an increase in intracellular ROS.  
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Due to the established antimicrobial activity of copper,7 copper oxide NPs have 
been also evaluated as antimicrobial agents by us8,9,10 and others.11,12 In that vein, Cu2O 
NPs of 16 nm and 12 nm exhibit IC50 values of 2.13 μg/mL and 3.7 μg/mL against 
Bacillus cereus and B. subtilis.9 "Naked" CuO NPs with particle size 20 ± 1.24 nm were 
more effective in regard of bacterial growth inhibition towards Staphylococcus aureus, 
Escherichia coli, B. subtilis and Pseudomonas aeruginosa by using both broth dilution 
and Kirby Bauer disc diffusion method. By the disc diffusion method the maximum 
zone of inhibition (ZOI) was recorded against B. subtilis (24 mm) and S. aureus (22 
mm), while the lowest minimum inhibitory concentration (MIC) value was recorded in 
case of E. coli (20 μg/mL).11 Concerning their mechanism of action, although there is 
still lack of sufficient knowledge,13 different activity pathways are suggested for the 
two copper oxides (I and II), with the involvement of ROS mainly in case of CuO NPs.14 
There are limited studies evaluating the anticancer activity of CuO NPs. Towards this 
direction CuO NPs of 22 nm size were tested in human hepatocellular carcinoma cells 
(HepG2) and the results showed that cell viability decreased gradually to 28% when 
cells were exposed to higher concentrations of  CuO NPs.15 In another study, CuO NPs 
(~30 nm) were applied in human breast cancer cell line MCF7 to correlate autophagy 
with apoptosis and the results demonstrated that the NPs induce in vitro growth 
inhibition and autophagy in the cells.16 Despite the fact that in both studies increase in 
the ROS production is involved, ROS and cancer are associated in a paradoxical 
manner; ROS and oxidative stress induce carcinogenesis, but higher increase of ROS 
levels enhance cell death.17 It has to be mentioned that the absence of any protecting 




 Polyethylene glycolation (PEGylation) offers stealth characteristics, which 
referred also as the enhanced permeation and retention effect (EPR). As a result of the 
EPR effect, PEGylated NPs can penetrate through the leaky vasculature of the tumor 
cells, whereas the normal tissue has a tight vasculature.18,19 Moreover, PEGylated NPs 
are able to avoid the non-specific interactions with opsonic proteins and uptake by the 
reticulo-endothelial system (RES) and this is very crucial in case of in vivo applications. 
However, CuO nanoparticles coated with polyethylene glycols are scarcely reported in 
the literature. Submicron CuO nanomaterials were prepared through hydrothermal 
method in the presence of very low concentrations (2μM) of PEG 20000 and found to 
exhibit higher antibacterial activity than CuO nanomaterials prepared through co-
precipitation routes, mainly through ROS production and lipid peroxidation.20 
 Herein, we chose to prepare PEGylated CuO NPs of different sizes with stealth 
characteristics to investigate their anticancer performance. Towards this goal, CuO NPs 
of different sizes were hydrothermally synthesized in the presence of either 
polyethylene glycol 1000 or polyethylene glycol 8000 upon adjusting properly the 
reaction temperature and time, since dissolution and crystallization processes take 
place. Their effects were evaluated on human cervical carcinoma HeLa cells while 
human immortalized embryonic kidney 293 FT cells were used as a control. HeLa cells 
were selected since are one of the best characterized human cell lines and one of the 
most popular cellular models in science and industry. Apart from the ROS production, 
which was measured by the nitroblue tetrazolium (NBT) reduction, cell membrane 
damage was also investigated by testing for lactate dehydrogenase (LDH) release. The 
DNA from the cells was isolated and studied for apoptotic fragmentation signs.  
Moreover, based on the close relationship between cancer and inflammation,21 the anti-
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inflammatory activity of CuO NPs was also studied in vitro by evaluating the inhibition 




Copper(II) nitrate trihydrate (Merck, ≥ 99.5%, M=241.60 g/mol, 
Cu(NO3)2·3H2O), hydrazine hydrate (Merck, ∼100%, M = 50.06 g/mol, N2H4·H2O), 
polyethylene glycol 8000 (Merck, M = 8000 g/mol), polyethylene glycol 1000 (Merck, 
M = 950 g/mol) were of analytical grade and were used without any further purification. 
Tissue culture coverslips (13 mm) were bought from Sarstedt. Microscope slides were 
provided from Superfrost (O. Kindler GmbH). Culture medium DMEM (Dulbecco’s 
modified Eagle’s medium with L-glutamine), fetal bovine serum (FBS), antibiotic–
antimycotic, and phosphate buffered saline (PBS, pH = 7.2) were obtained by E.U 
Gibco BRL. Trypsin + EDTA and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT powder) were purchased from Invitrogen. All 
reagents were used without any further purification. 
Preparation of CuO NPs. All the synthetic routes followed the same procedure of 
hydrothermal synthesis into a 23 mL Teflon-lined stainless-steel autoclave. The 
surfactants that have been used were either PEG 1000 or PEG 8000. Experimental 
results are summarized in Table 2. The reaction time and temperature were varied from 
6 to 12 hours and from 150 to 160 oC, respectively, while the ratio of precursor to 
reducing agent (1:1) as well as precursor to surfactant ratio (1:1) were kept the same in 
all the experiments.  
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 In a typical synthesis (e.g. Sample S1), 2 mmol (0.5 g) Cu(NO3)2
.3H2O were 
dissolved in 10 ml deionized water to obtain a blue solution. Then 2 mmol (0.103 g) 
N2H4
.H2O were added dropwise to the solution under vigorous stirring and the color 
changed from blue to yellow, indicating the reduction of Cu2+. A solution of 2 mmol (2 
g) PEG 1000 was added and the resulting mixture was stirred thoroughly and then 
transferred into the autoclave, while the crystallization was carried out under 
autogenous pressure. Afterwards, the autoclave was cooled gradually to room 
temperature and after centrifugation at 5000 rpm for 20 min, the supernatant liquids 
were discarded and the precipitates were obtained and washed with ethanol, at least 
three times, in order to remove the excess of ligands and unreacted agents.  
NPs Characterization  
X-Ray powder diffraction graphs (XRD) were recorded at Bragg-Brentano (BB) 
geometry using a two-cycles Rigaku Ultima+ powder X-ray diffractometer with a Cu 
Ka radiation operating at 40 kV/30 mA. Transmission Electron Microscopy (TEM) 
images were obtained with a JEOL 100 CX microscope, operating at an acceleration 
voltage of 100 kV. For TEM observations we have used suspensions of the 
nanoparticles deposited onto carbon-coated copper grids. The dynamic light scattering 
(DLS) and zeta potential measurements were performed with a Malvern Zetasizer 
instrument. Infrared spectra (280-4000 cm-1) were recorded on a Nicolet FTIR 6700 
spectrometer with samples prepared as KBr pellets. Thermogravimetric analysis (TGA) 
was performed using SETA-RAM SetSys-1200 and carried out in the range from room 
temperature to 900 oC at a heating rate of 10 oC min-1 under N2 atmosphere. The ionic 
release was determined by flame atomic absorption spectrophotometry (FAAS) using 






HeLa and 293 FT cell lines were cultured in DMEM supplemented with 10% FBS and 
the antibiotics penicillin and streptomycin. The cell lines were maintained in culture at 
37 °C, in 5% CO2, in a humidified incubator, using standard aseptic techniques and cell 
growth was monitored by determining the cell number with the use of a Neubauer 
hemocytometer. 
Viability assay (MTT) 
Cells were seeded in 96-well plates at a density of 5 × 103 cells per well and incubated 
for 24 h to allow cell growth. Titration experiments were performed in order to evaluate 
the cell viability upon increasing concentrations ranging from 5-100 μg.mL−1 of the 
NPs. Towards this purpose the cells were further incubated with the respective NPs 
suspensions for 24 h. Cells that were not exposed to NPs served as control. At this point 
cell growth was measured by monitoring the conversion of 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to formazan, since the 
reduction of MTT is catalyzed by mitochondrial dehydrogenase enzyme. Briefly, 24 h 
after the addition of the NPs to the cells the medium was removed from each well and 
replaced with 100 μL fresh medium containing 10 μL MTT 20 mM (5 mg.mL−1) per 
well. After another incubation for 4 h at 37 °C (until the development of the purple 
colored formazan product) 100 μL of Sodium Dodecyl Sulfate (SDS) 10%–HCl 0.01 
M were added to the cells and incubated in the dark for 15 min. The absorbance was 
measured at dual wavelength 570 nm and 630 nm using a Bio-Tek Microplate 
AutoReader 311SX (BIO-TEK Instruments INC, USA). Each sample was triplicated. 
For statistical analysis, Student’s t-test was performed to evaluate the difference 
between samples and control, while differences among the samples and the cell lines 
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were analyzed by One Way Analysis of Variance (ANOVA) followed by Tukey test. 
Statistical significance was considered at p < 0.05. 
Lactate dehydrogenase assay (LDH)  
Lactate dehydrogenase leakage (LDH), which is a measure of cytotoxicity on the basis 
of membrane integrity damage, was determined using a commercial LDH Kit 
(Biochain) according to the manufacturer’s protocols. This procedure is based on the 
method developed by Ulmer et al.,22 optimized for greater sensitivity and linearity. 
HeLa cells were seeded in 96-well culture plate at a density of 2 x 104/mL in DMEM 
supplemented with antibiotics penicillin and streptomycin but without FBS in order to 
avoid the background of the serum. After 16 hours of incubation at 37 °C in a 
humidified atmosphere containing 5% CO2, CuO NPs (samples S1-S5) at the 
concentrations of 5, 10, 25, 50 and 100 μg ml−1 were added. The cells with the NPs 
were incubated for 24 h while non-exposed cells were used as negative controls. Then, 
the cell culture medium was collected for LDH measurement. An aliquot of 100 μl cell 
medium was used for LDH activity analysis and the absorbance at 490 nm was 
measured using a Bio-Tek Microplate AutoReader 311SX (BIO-TEK Instruments INC, 
USA). Each sample was triplicated. For statistical analysis, Student’s t-test was 
performed. Statistical significance was considered at p < 0.05. 
Nitroblue tetrazolium assay (NBT)  
The reactive oxygen species (ROS), which are created intracellularly as result of 
treatment of HeLa cells with CuO NPs, were measured by the nitroblue tetrazolium 
(NBT) reduction using the protocol described by Becerra et al.23 For this purpose 100 
μL cell suspension (cell culture was incubated overnight) in DMEM was incubated with 
respective CuO NPs (samples S1-S5) and 500 μL of 1 mg/mL NBT for 1 h at 37 oC. 
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Then, 100 μL of 0.1 M HCl was added and the tubes were centrifuged at 1500 g for 10 
min. The pellets were treated with 600 μL DMSO to extract the reduced NBT. Finally, 
500 μL DMEM was added and formazan blue obtained from cells was measured as 
optical density (OD) at 575 nm (intracellular ROS). 
 
Genomic DNA isolation from HeLa cells exposed to CuO NPs 
Cells were seeded in 96-well plates at a density of 5 × 103 cells per well and incubated 
for 24 h to allow cell attachment. After the addition of 10 and 100 μg.mL−1 of the CuO 
NPs, the cells were further incubated with the NPs suspensions for 24 h. Then, the 
cultures were washed three times with PBS and were pelleted in a micro centrifuge 
tube. The cell pellets were resuspended in 200 μl of lysis buffer [2% Triton X-100, 1% 
SDS, 100 mM NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0)]. The tubes 
were placed on ice for two minutes (until they were completely frozen), then immersed 
in a 95 °C water bath for 1 minute to thaw quickly and finally were vortexed vigorously 
for 30 seconds. The process was repeated twice.24 After centrifugation for 5 min at 1600 
x g the supernatants are collected, brought to 1% SDS and treated for 2 h with RNase 
A (final concentration 5 μg/mL) at 56 °C followed by digestion with proteinase K (final 
concentration 2.5 μg/mL) for at least 2 h at 37 °C. After addition of 1/2 volume 10 M 
ammonium acetate, the DNA is precipitated with 2.5 volume ethanol.25  
DNA binding/cleavage experiment in agarose gel electrophoresis 
The DNA binding/cleavage efficiency of the NPs was measured by determining their 
ability to alter the mobility of the isolated DNA and/or to cause degradation. Upon the 
addition of 5 μL loading buffer consisting of 0.25% w/v bromophenol blue and 30% 
v/v glycerol in water,  the products resulting from interactions of the NPs with DNA 
were separated by electrophoresis on agarose gels (1% w/v), which contained 1 μg/mL 
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ethidium bromide in 40·10-3 M Tris–acetate, pH 7.5, 2·10-2 M sodium acetate, 2·10-3 
M Na2EDTA, at 5 V·cm
-1. Agarose gel electrophoresis was performed in a horizontal 
gel apparatus (Mini-SubTM DNA Cell, BioRad) for about 1 h. The gels were visualized 
after staining with the fluorescence intercalated dye ethidium bromide under a UV 
illuminator.  
 
Evaluation of lipoxygenase activity 
The reaction mixture contained (final concentration) the CuO NPs (samples S1-S5), 
dissolved in water at concentrations of 2-10 μg.mL-1, or the solvent (control), soybean 
lipoxygenase, dissolved in 0.9% NaCl solution (250 u.mL-1 final concentration) and 
sodium linoleate (100 μM), in Tris–HCl buffer, pH 9.0. The reaction was monitored for 
9 min at 28 οC, by recording the absorbance of a conjugated diene structure at 234 nm, 
due to the formation of 13-hydroperoxy-linoleic acid. The performance of the assay 
was checked using naproxen as a reference. 
 
Results and discussion 
Synthesis and characterization of CuO NPs 
 For the synthesis of CuO NPs a simple hydrothermal procedure into a Teflon-
lined stainless-steel autoclave was employed. Generally, hydrothermal synthesis of 
CuO NPs are governed both by thermodynamic and kinetic growth. The depicted 
experimental conditions were based on our previous results as the composition of Cu-
based NPs is strongly influenced by specific reaction parameters.8-10 Solution pH and 
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temperature are the factors which affect the mixed potential, and thus the most stable 
chemical species can be changed by the pH and temperature.26,27 The stabilization of 
CuO NPs occurs in the temperature range of 150 to 160 oC in reaction time longer than 
4 hours. By differentiating both the molecular weight (MW) of the surfactant and the 
reaction times, NPs in a range of primary sizes can be isolated, in accordance with PEG 
MW that has a strong influence on the viscosity of the solution. PEG with high MW 
(>6000) decrease the dispersion of the metal salt, as behaves like a linear hydroxyl 
polymer, which is very hydrophilic in nature. It restricts the migration of the metal ions 
and thus affects the size of the nanoparticles.28 It has to be mentioned that crystallinity 
of the final product will not be affected much when using different MW PEG.20 The 
reductive ability of polyethylene glycols is an effective way to adjust the redox 
reactions and the crystallization of copper oxides, while the size of the NPs strongly 
depends on time as the competition between Ostwald ripening and dissolution took 
place.29 Meanwhile, the pH of the reaction suspension has been initially adjusted at 298 
K by using the same amount of reducing agent, hydrazine, in all the experiments. In 
that manner, five different samples of CuO NPs (S1-S5) were prepared by 
differentiating the reaction time and in the presence of the biocompatible surfactants 
polyethylene glycol 1000 and polyethylene glycol 8000. The reaction time and 
temperature were varied from 6 to 12 hours and from 150 to 160 oC, respectively 
concerning that the long chain polyols exhibit weaker reductive ability than those of 
lower molecular weight, in respect of PEG 8000 and PEG 1000. Table 1 summarizes 
the experimental procedures and the main characteristics of the resulted NPs. 
 The phase composition and crystalline structure were determined via XRD 
measurements (Figure 1). All samples exhibited the monoclinic structure of CuO 
(ICDD, JCPDS card No. 80-1916). The average crystalline sizes of the NPs of all the 
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samples were determined by measuring the full width at half-maximum (FWHM) of 
the most intense peaks and using the Scherrer equation (Table 1). Lattice parameters 
were also calculated by using MDI's Jade software and the corresponding values 
presented in Table 1, are in good agreement with the standard values reported by the 
JCPDS card No 80-1916, demonstrating the high crystallinity of the samples. 
 
Figure 1. XRD patterns of samples S1-S5. Vertical lines denote expected diffraction 
peak positions for CuO.  
 TEM micrographs of sample S1 prepared in the presence of PEG 1000 and 
samples S2, S3 and S4 in PEG 8000 are illustrated in Figure 2. Both polyethylene 
glycols resulted in the formation of NPs of similar morphology. It has to be mentioned 
that CuO NPs present different morphology when they are prepared upon oxidation of 
copper nanoparticles. In our previous study, Cu NPs coated with PEG 8000 were 
oxidized over time to leaf-like structured CuO NPs,9 while the same shape has been 
reported also for CuO nanocrystals prepared either by oxidizing copper NPs in 
hexadecyl trimethyl ammonium bromide  solution (CTAB)30 or through pulsed copper 





Figure 2. TEM images and size distributions of samples S1 (a), S3 (b), S4 (c) and S2 
(d). 
 The as prepared NPs are readily dispersible in aqueous solution due to the in 
situ hydrophilic surface coating. The colloidal stability of the CuO NPs is an important 
issue relating to their biological properties. Thus, the samples were dispersed in 
phosphate buffered saline (PBS) after the synthesis without any further modification 
and by the means of DLS measurements their hydrodynamic size was determined and 
presented in Table 1. The free hydroxyl groups extending from the surface of the 
nanoparticles enable the electrostatic stabilization of the NPs with the steric exclusion 
forces leading to their stabilization in PBS. PEGylation refers to a typical state of steric 
exclusion where based on the amount of PEG on the surface of the nanoparticles 
provides a steric barrier.32 The hydrodynamic size for samples S1 and S5 coated with 
PEG 1000 was determined as 998 nm and 1120 nm respectively, while samples S2, S3 
and S4 coated with PEG 8000 displayed much lower values (330-389 nm). The 
polydispersity index was found in the range of 0.2-0.4 and the zeta potential 
measurements revealed the slightly negative charge on the surface of the NPs dispersed 
in PBS (-13 mV to -1.03 mV). The lower molecular weight of PEG 1000 in combination 
with the lower amount of surfactant on the surface of the NPs (as indicated by the TGA 
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curves, Fig. 4) allows for aggregation. On the contrary, in case of PEG 8000, the size 
of the NPs is more indicative of clustering and network formation.  
 The presence of the surfactants has been testified by FT-IR spectroscopy. FT-
IR spectra of the samples S1, S5 and S2-S4 with the corresponding patterns of PEG 
1000 and PEG 8000 are given in Figure 3(a) and 3(b) respectively for comparison 
reasons. In all samples medium peaks at about 2920 cm-1 and 2860 cm-1 are assigned 
to the asymmetric (νas) and symmetric (νs) stretching vibrations of methylene (–CH2) 
groups, common in both surfactant molecules. The broad peak around 1643 cm-1 is 
ascribed to the hydrogen bonds, formed from the hydroxide groups while the C-O-C 
ether stretch band at 1106 cm-1 is indicative of the presence of polyethylene glycols. 
The peaks located at the region 500-540 cm-1 are assigned to CuO metal – oxygen bond, 
being recorded in all samples and further verifying the composition and are in 
agreement with the absence of Cu2O. In its crystal lattice CuO is connected to four 
oxygen atoms in a square planar geometry, whereas Cu2O is linked with two oxygen 
atoms in a linear coordination. Therefore, the Cu(II)-O bonds in CuO are weaker than 
Cu(I)-O bonds and the vibration of the Cu-O bond in CuO appears in lower frequencies 
















































Figure 3. FTIR spectra of: (a) PEG 1000 and samples S1, S5 (b) PEG 8000 and samples 
S2, S3 and S4. 
 
 The amount of organic coating on the surface of the nanoparticle was evaluated 
by thermogravimetric analysis (TGA) over a temperature rate up to 800 °C under 
nitrogen atmosphere and the curves are given in Figure 4 (a) and (b) for samples S1 
and S5 and samples S2-S4 respectively. The decomposition temperature of all pure 
surfactants is in the vicinity of 400 oC, while changes are attributed to the way of 
binding/adsorbing on the metal core. Similar thermal behavior occur to each set due to 
the same surfactant, while the cumulative organic content was estimated 33 wt% and 
22 wt% for samples S1 and S5, respectively and 45 wt%, 39 wt% and 50 wt%, for 
samples S2, S3 and S4 respectively. The decomposition of PEG 1000 occurs in either 
one (S1) or two steps (S5)  up to 350 °C, depending on the type of conformation, tight 
or loose, of the surfactant onto the nanoparticles. In case of samples S2 and S3 PEG 
8000 was eliminated in three steps, while a different behavior was observed in the 
sample S4, where the decomposition occurs in four steps in a wider temperature range. 
Controversial explanations can be found in literature for decomposition in higher 
temperatures, since multi-stepped TGA curve is attributed to either a bi-layer formation 
of the organic coating34 or to two different kinds of binding sites.35 
(a)



















































Figure 4. (a) Thermogravimetric curves of PEG 1000-capped (S1 and S5) and (b) PEG 
8000- capped (S2, S3, S4) NPs under nitrogen flow with a temperature increase of 10 
oC/min. 
 
 On the base of the obtained TGA results, the number of PEG molecules per one 
NP have been estimated. The calculations for samples S1-S5 were performed under 
assumption that the density of the nanoparticles (6.5 g/cm3) is the same for the above 
samples and that their shape is totally spherical.36 As a result the number of ligands that 
are bound on the NPs was calculated (Eq. 1) and found 5693 and 3144 for S1 and S5, 
and 389, 133, 1024 ligands per particle for S2, S3 and S4, respectively. 
                                 𝑁 =
𝜔 𝑁𝐴  𝜌 
4
3
 𝜋 𝑅3 ×10−23 
𝑀
                                            (1) 
Where N is the number of ligands on each particle, R is the mean radius of the CuO 
NPs, ρ is the density of the NPs, NA is Avogadro’s number, M is the molar mass of 
surfactant molecules (g/mol) and ω is the mass loss in percent (%).  
 In general, the biological activity of the NPs is strongly affected not only by 
their size and shape, but also by the conformation of PEG molecules on the surface of 
the NPs. Coating of NPs with PEG 1000 resulted in dramatic increase of hydrodynamic 
diameter of the NP (Table 1), while no significant increase of hydrodynamic diameter 
resulted in case of PEG 8000. This behavior is associated with the different grafting 
density of PEG 1000 and PEG 8000. In the latter case, the fewer PEG molecules may 
led in mushroom conformation, while in case of smaller MW as PEG 1000 brush 
conformation is expected, as reported also previously.37 Meanwhile, the conformation 
of PEG favors or not the ionic release from the NPs into the medium and affects the 
biological activity of NPs.13,38,39 Thus, CuO NPs have been incubated into PBS solution 
for 48 h in a rotary shaker and the ionic release has been measured (Table 1).  
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Table 1. Summary of experimental results and main characteristics of samples S1-S5. 













Ionic release per 
100 μg/mL 
S1 PEG1000 160 6 20 4.74, 3.42, 5.12 998 2.108 
S5 PEG1000 160 8 18 4.74, 3.42, 5.13 1120 3.44 
S2 PEG8000 150 12 15 4.68, 3.42, 5.13 378 2.272 
S3 PEG8000 150 10 11 4.69, 3.41, 5.11 389 0.832 
S4 PEG8000 150 8 20 4.72, 3.42, 5.12 330 2.497 
 
Viability assays (MTT) 
In order to investigate the potential use of the CuO NPs in cancer therapy, MTT 
assays were performed to evaluate how the PEGylated NPs of different sizes affect the 
viability of human cervical carcinoma (HeLa) cells by using human immortalized 
embryonic kidney (293 FT) cells as control cell line. Our data revealed that upon 
addition of low concentrations (5-10 μg/mL) of the NPs there is a significant decrease 
in viability of human cervical carcinoma, while NPs affected less the control cell line 
293 FT (Figure 5). Higher concentrations of NPs (25-100 μg/mL) resulted in a more 
intense stimulus in cancer cell line as compared to the control. The HeLa cells appear 
more sensitive even at the lowest concentration tested (5 μg/mL). In the presence of 
CuO@PEG 1000 NPs of primary size 20 nm (sample S5) the cell viability was 63.5%, 
whereas in 293 FT cells was 98.7% respectively. Furthermore, the observed viability 
for the concentration of 10 μg/mL differs significantly between the two cell lines. The 
higher difference was recorded in case of sample S2 (primary size 15 nm). In that case, 
the cell viability in HeLa cells was reduced to 52.3%, while the corresponding value in 
293 FT cells was 86.6%.  
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By implementing ANOVA followed by Tukey, a comparison of the observed 
biological effects among the samples covered either with PEG 1000 or PEG 8000 was 
reported and the results did not record any statistical difference. The density and the 
molecular weight of PEG chain affected the stealth properties; the brush conformation 
may result to better flexibility of the NPs, while a mushroom regime could provide 
better protection of the metal core.18,19,37 It has to be mentioned that CuO NPs of 
primary size 11 nm (sample S3) could not distinguish between normal and cancerous 
cells. The IC50 value, which is defined as the lowest concentration of a compound or 
material that inhibits the 50% of the cell growth,7 was determined based on growth 
inhibition of cell cultures, containing varying concentration of the NPs in suspension. 
Upon the use of 11 nm CuO NPs the IC50 values recorded for 293 FT and HeLa cells 
were 29.7 and 25.8 μg/mL respectively, attributed mainly to their smaller size (Table 
2). Recently, the use of engineered nanoparticles for drug delivery in cancer therapy 
has been reviewed and the size of the NPs has been denoted as a crucial factor affecting 
the way of internalization inside the cells. In case of small nanoparticles (<20 nm) either 
pinocytosis or diffusion could occur instead of other selective endocytosis processes.36  
a) b)  
Figure 5. MTT assay in (a) HeLa cell line and (b) 293 FT cells. Data represented are 
mean ± SD of three identical experiments made in three replicates (asterisk denotes 




 By comparing the IC50 values among the samples, a similar activity is exhibited, 
with the lowest value (11.91 μg/mL) in the cancer cell line being recorded in case of 
CuO NPs with primary and hydrodynamic size 20 nm and 1120 nm, respectively. Those 
NPs released more ions in the medium (3.44 μg/mL) in comparison with the other 
samples and even though the value is relatively low, the ionic contribution to the 
activity of the NPs cannot be excluded. Similar value was reported (~14 μg/mL) in a 
previous study of 30 nm "naked" CuO NPs towards MCF7 cells,16 while when 10 
μg/mL of 22 nm "naked" CuO NPs were applied to HepG2 cells, the cell viability 
decreased to 52%.15 Although samples S2, S3, S4  have very similar hydrodynamic 
diameter, sample S3 has the smallest number of ligands per particle and exhibited the 
lowest IC50 (25.78 μg/mL) towards the control cells 293FT. In that case the leaching of 
ions was found negligible (0.832 μg/mL) indicating that manner the close-packed 
conformation of the PEG molecules which resulted in better protection of the core. 
Thus, the activity arises mainly from the nanosized effect. 
 
Table 2. Anticancer activity of CuO NPs evaluated by the half-minimal inhibitory 
concentration (IC50) (μg/mL). 






S1 49.12 19.58 
S2 56.42 13.93 
S3 29.68 25.78 
S4 64.65 24.17 




Nitroblue Tetrazolium Assay (NBT) 
 The physicochemical characteristics of the NPs (composition, size, shape)37 as 
well as the characteristics of the NP target cell, i.e. the cell type,38 affect their anticancer 
activity, since they interfere with their ability to selectively enter into the tumor cells. 
Apart from this fact, the cause of oxidative stress is also under investigation, since in 
previous study the biological activity of CuO NPs has been attributed mainly to ROS 
production.14 The results of the NBT assay demonstrate that the NPs induced oxidative 
stress in the HeLa cultures associated with the increase of O2
− in the cell cytoplasm 
(Figure 6) in agreement with previous studies. A significant dose-dependent response 
was observed in the assay for all the samples, while no significant differences among 
the samples are reported. In general, low concentrations stimulated the generation of 
O2
− with a moderate manner while a maximum stimulus in higher concentration tested 
(50 μg/mL) was found. This result supports that the anticancer activity of CuO NPs is 
mediated through oxidative stress. Previously it has been reported that CuO NPs can be 
the primary source of ROS if the release of Cu2+ ions is very low,13 as it happens in the 
present study. The strong adherence of the NPs to the cell membrane in combination 
with the production of ROS on the surface of the particles, cause an increase in cell 
permeability, leading to an uncontrolled transport of CuO NPs through the cytoplasmic 
membrane and ultimately to cell death. As mentioned previously, on the one hand ROS 
promote proliferation, angiogenesis and in that manner carcinogenesis; elevated ROS 
level activate constantly transcription factors. On the other hand, though, even higher 
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Figure 6.  Intracellular O2
- generated by CuO NPs (samples S1-S5) in HeLa cell line 
detected by nitroblue tetrazolium assay. 
 
Lactate Dehydrogenase assay (LDH)  
 The amount of LDH of the cells after 24 h of incubation in the presence of the 
NPs was also estimated. All samples induced apparent LDH leakage from HeLa cells 
treated for 24 h, which revealed the impact of nanoparticles on cell membrane integrity 
(Figure 7). LDH levels in cell medium were low up to the concentration of 10 μg/mL, 
whereas at the higher doses the LDH levels were elevated rapidly. The results are in 
accordance with those of the MTT and NBT assays, as a general trend. The biggest in 
terms of hydrodynamic and primary size CuO NPs cause the highest release of LDH, 
suggesting physical damage on the cellular membrane rather than solely crossing 
through the cell membrane and entering the cytoplasm. In the smaller CuO NPs 
membrane damage is exerted mainly via ROS generation as indicated by NBT assay 
and not through direct contact. The direct contribution of ions released to the medium 
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Figure 7. LDH leakage from HeLa cells after 24 h treatment with samples S1-S5. Cells 
were respectively treated with 5, 10, 25, 50 and 100 μg ml−1 of CuO NPs for 24 h. 
Results are the mean ± SD of three independent experiments each carried out in 
triplicate. Statistically significant difference as compared to the controls (p<0.05 for 
each). 
DNA degradation after exposure to NPs in agarose gel electrophoresis 
 The effect of the NPs on DNA isolated from HeLa cells treated for 24 h at 37 
°C with 10 and 100 μg/mL of samples S1-S5 was studied. A representative 
electrophoretic pattern of agarose gel electrophoresis is shown in Figure 8. DNA 
isolated from untreated cells exhibit one major characteristic band of unaffected/intact 
chromosomal DNA (Lane C: control), while DNA isolated from cells treated with the 
NPs exhibit several bands almost equally distant revealing degradation of nucleosomes, 
a very characteristic pattern similar to a ladder or apoptotic DNA laddering due to 
cleavage of chromatin DNA into internucleosomal fragments of roughly 180 base 
pairs (bp) and multiples thereof (360, 540 etc.). Because DNA portions of nucleosome 
core particles are less accessible for NPs than linking sections, DNA gets digested into 
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fragments of lengths equal to multiplicity of distance between nucleosomes. This result 
indicates that the NPs either managed to enter the cells and to assault directly nuclear 
DNA by mimicking or by inducing endonuclease activity or ROS production and ionic 
release took place which affected indirectly the DNA integrity. 
Figure 8. Dose-dependent DNA degradation action of the NPs in agarose gel 
electrophoresis. Lane C: DNA without treatment with NPs (control); Lanes 1-2: DNA 
treated with 10 and 100 μg/mL of 15 nm CuO@PEG8000 NPs (S2); Lanes 3–4: DNA 
treated with 10 and 100 μg/mL of 18 nm CuO@PEG1000 NPs (S5); Lanes 5-6: 10 and 
100 μg/mL of 20 nm CuO@PEG8000 NPs (S1); Lanes 7-8: DNA treated with 10 and 
100 μg/mL of 11 nm CuO@PEG8000 NPs (S3); Lanes 9-10: DNA treated with 10 and 
100 μg/mL of 20 nm CuO@PEG8000 NPs (S4). As DNA markers the 1 kb ladder was 
used. 
DNA isolated from HeLa cells treated for 24 h at 37 °C with 10 μg/mL of 15 
nm CuO@PEG8000 NPs or 20 nm CuO@PEG1000 NPs (Lanes 1,3 Figure 8) has been 
degraded, since bands of lower molecular weights appeared in the gel. The higher 
concentration (100 μg/mL) in the first case resulted in significant degradation effect, 
while in the latter case complete degradation of the DNA (lane 4) was observed. The 
DNA integrity was also affected in the presence of 18 nm CuO@PEG1000 NPs (lanes 
 Ladder    1            2            3            4           5          6       
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5,6), of 11 nm (lanes 7,8) and 20 nm (lanes 9,10) CuO@PEG8000 NPs as indicated by 
the DNA fragmentation observed in all cases.  DNA fragmentation can be considered 
as one of the biomarkers that characterize apoptosis.40 By taking into account the DNA 
interaction could be achieved either directly or indirectly, the size of the nanoparticles 
(hydrodynamic and/or primary) becomes the crucial factor that determines whether the 
NPs enter into the cytoplasm and the nucleus. The hydrodynamic size of the NPs was 
determined in PBS (pH = 7.2). However, we have to take into account that the acidic 
conditions of tumors favor the dissolution of NPs and thus NPs could enter selectively 
on cancer cells and interact directly with subcellular organelles.41 The smaller NPs 
(primary size 11-20 nm) could direct interact with the DNA,42 while an indirect effect 
on DNA through the production of ROS is supported by the bigger sizes.43 However, 
the latter mechanism of action or synergistic effects cannot be excluded also for the 
smaller NPs.  
 
In vitro inhibition of soybean lipoxygenase (LOX) 
It is generally accepted that there is a close association between cancer and 
inflammation.44 Therefore, oxidative enzymes that are known to play a key role in 
inflammation are increasingly investigated in connection to cancer. Lipoxygenases are 
a group of oxidative enzymes with a non-heme iron atom in their active site, which are 
involved in the regulation of inflammatory responses through catalyzing the insertion 
of oxygen (O2) into poly-unsaturated fatty acids such as arachidonic acid and linoleic 
acid. In the catalytic reaction, Fe3+ is reduced to Fe2+ with concomitant oxidation of the 
lipid substrate by hydrogen abstraction from a bis-allylic methylene to give a 
pentadienyl radical, which is re-arranged to provide a 1-cis,3-trans-conjugated diene 
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moiety. Subsequently, a stereo-specific insertion of oxygen at the pentadienyl radical 
takes place to form an oxygen-centered fatty acid hydroperoxide radical, which are 
mediators of inflammation.45  
Generation of ROS, rapid LDH release indicative of membrane damage and 
DNA damage were reported and are the main factors affecting the mechanism of action 
of the NPs. In a previous study, lipoxygenase inhibitors induced apoptosis in breast 
cancer cells in vitro.46 Thus, to account for the anti-inflammatory activity of the CuO 
NPs, the inhibitory effect on the lipoxygenase enzyme activity was investigated. In all 
cases, enzyme inhibition is observed in a concentration-dependent manner, while the 
IC50 values did not differ significantly among the samples (Table 3). Figure 8a and 8b 
shows indicative curves of samples S4 and S5, respectively, exhibiting high LOX 
inhibition with the half maximal inhibitory concentration (IC50) values being 4 and 4.5 
μg/mL, respectively (Table 3). The enhanced activity of the CuO NPs as compared to 
the control naproxen (5.5 μg/mL) could be attributed to their smaller size, which 
probably allows for closer interaction with the LOX enzyme.  
 
Figure 9. LOX inhibition in (a) sample S4 and (b) sample S5 upon increasing 
concentrations (1: 2.5 μg/mL, 2: 5 μg/mL, 3: 10μg/mL, 4: 25 μg/mL and 5: 50 μg/mL).  
Table 3. Anti-inflammatory activity of CuO NPs evaluated by the half-minimal 
inhibitory concentration (IC50) (μg/mL). 







































































IC50  (μg/mL)  
S1  5.9  
S2  4.8  
S3  5.3  
S4  4  
S5  4.5  
 
Conclusions  
PEGylated CuO NPs in a range of sizes (11-20 nm) were synthesized by varying the 
reaction time upon properly adjusting the temperature and pH. PEGylation offers not 
only high colloidal stability, but also protein resistance allowing for selective detection 
of biological targets due to their stealth characteristics. The results concerning the 
anticancer activity of the NPs indicated a trend of differential viability between HeLa 
cells and 293 FT cells, while a concentration-dependent behavior in all cases was also 
demonstrated. The NPs exhibited enhanced selectivity that led to selective apoptosis of 
tumor cells through DNA damage and ROS generation, and/or by causing membrane 
damage through direct physical contact. The in vitro anti-inflammatory activity was 
evidenced as the CuO NPs inhibited efficiently the lipoxygenase enzyme. These 
promising results enable for extension of the studies to different cancer cell lines in 
accordance with in vivo studies, while further functionalization of the NPs with 
magnetic nanoparticles could improve also their targeted biological activity. PEG 
molecules have the potential to become multifunctional upon combining with 
fluorescent agents or other functional groups, while can be used as a matrix for drug 
loading, as previously reported by us.47 In this respect, PEGylation chemistry can be 
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extended as an inherent part of the therapeutic, diagnostic, and imaging platform in 
addition to  the passive coating for the repulsion of opsonin proteins. 
Abbreviations 
NPs Nanoparticles 
PEG 1000  polyethylene glycol 1000 
PEG 8000 polyethylene glycol 8000 
Cu NPs  Copper nanoparticles 
CuO cupric oxide 
HepG2 human hepatocellular carcinoma cells 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide 
ROS reactive oxygen species 
NBT Nitroblue Tetrazolium 
TGA Thermogravimetric analysis 
TEM Transmission Electron Microscopy 
DLS Dynamic Light Scattering  
LDH lactate dehydrogenase 
LOX Lipoxygenase 
MIC (IC50) Minimum Inhibitory Concentration 
EPR Enhanced permeation and retention 
RES reticulo-endothelial system 
HeLa human cervical carcinoma 
Eth Br ethidium bromide 
DMEM Dulbecco’s modified Eagle’s medium 
with L-glutamine 
SDS Sodium Dodecyl Sulfate 
EDTA ethylenediaminetetraacetic acid 
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